Lushang Freda Pharmaceutical Co.,Ltd.
600223.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.93B
Close$
Share Statistics
| Market cap | $5.93 Billion |
|---|---|
| Enterprise Value | $3.31 Billion |
| Dividend Yield | $0.06 (0.98%) |
| Earnings per Share | $0.18 |
| Beta | 0.93 |
| Outstanding Shares | 1,016,568,775 |
Return
| Return on Equity | 3.80% |
|---|---|
| Return on Assets | 2.72% |
| Return on Invested Capital | 4.15% |
Valuation & Multiples
| P/E Ratio | 36.99 |
|---|---|
| PEG | -287.49 |
| Price to Sales | 1.94 |
| Price to Book Ratio | 1.46 |
| Enterprise Value to Revenue | 0.88 |
| Enterprise Value to EBIT | 15.83 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$1.01 B
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Lushang Freda Pharmaceutical Co.,Ltd.
3,514 employees
CEO: Chun Ming Gao Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides ...